Levofloxacin and ciprofloxacin decrease procainamide and N-acetylprocainamide renal clearances

被引：20
|
作者：
Bauer, LA
Black, DJ
Lill, JS
Garrison, J
Raisys, VA
Hooton, TM
机构：
[1] Univ Washington, Dept Pharm, Seattle, WA 98195 USA
[2] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA
[3] Univ Washington, Dept Pharm Serv, Seattle, WA 98195 USA
来源：
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2005年 / 49卷 / 04期
关键词：
D O I：
10.1128/AAC.49.4.1649-1651.2005
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
Ten healthy adults participated in a randomized, crossover drug interaction study testing procainamide only, procainamide plus levofloxacin, and procainamide plus ciprofloxacin. During levofloxacin therapy, most procainamide and N-acetylprocainamide (NAPA) pharmacokinetic parameters, including decreased renal clearances and renal clearance/creatinine clearance ratios, changed (P < 0.05). During ciprofloxacin treatment, only procainamide and NAPA renal clearances decreased significantly.
引用
收藏
页码：1649 / 1651
页数：3
相关论文
共 50 条
  • [31] MANDIBULAR AND PAROTID SALIVARY EXCRETION OF PROCAINAMIDE AND N-ACETYLPROCAINAMIDE AFTER INTRAVENOUS ADMINISTRATION OF PROCAINAMIDE TO RATS
    WATANABE, J
    KOYAMA, I
    IWAMOTO, K
    OZEKI, S
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 1987, 39 (11) : 912 - 916
  • [32] AN HPLC METHOD FOR THE SIMULTANEOUS QUANTITATION OF QUINIDINE, PROCAINAMIDE, N-ACETYLPROCAINAMIDE, AND DISOPYRAMIDE
    BRIDGES, RR
    JENNISON, TA
    JOURNAL OF ANALYTICAL TOXICOLOGY, 1983, 7 (02) : 65 - 68
  • [33] The influence of moderate and chronic exercise training on the pharmacokinetics of procainamide and N-acetylprocainamide
    Eddington, ND
    Adekoya, F
    Kharidia, J
    BIOPHARMACEUTICS & DRUG DISPOSITION, 1998, 19 (05) : 291 - 296
  • [34] HEMODYNAMIC-EFFECTS OF PROCAINAMIDE AND ITS MAJOR METABOLITE N-ACETYLPROCAINAMIDE
    ASKENAZI, J
    TOMMASO, CL
    GARDIN, JM
    CLINICAL RESEARCH, 1979, 27 (04): : A609 - A609
  • [35] CLINICAL PHARMACOLOGY OF N-ACETYLPROCAINAMIDE (NAPA), MAJOR METABOLITE OF PROCAINAMIDE IN MAN
    KLUGER, J
    REIDENBERG, M
    TYBERG, T
    LLOYD, V
    ELLIS, G
    HAYES, J
    DRAYER, D
    CLINICAL RESEARCH, 1978, 26 (03): : A244 - A244
  • [36] IMPROVED LIQUID-CHROMATOGRAPHIC DETERMINATION OF PROCAINAMIDE AND N-ACETYLPROCAINAMIDE IN SERUM
    PATEL, CP
    THERAPEUTIC DRUG MONITORING, 1983, 5 (02) : 235 - 238
  • [37] PROCAINAMIDE PHARMACOKINETICS IN BEAGLES - URINARY PH DEPENDENCY AND COMPARISON WITH N-ACETYLPROCAINAMIDE
    BAER, DT
    BARKUS, JC
    RESEARCH COMMUNICATIONS IN CHEMICAL PATHOLOGY AND PHARMACOLOGY, 1977, 17 (02): : 333 - 336
  • [38] FLUOROIMMUNOASSAYS FOR PROCAINAMIDE AND N-ACETYLPROCAINAMIDE COMPARED WITH A LIQUID-CHROMATOGRAPHIC METHOD
    MACKICHAN, JJ
    COYLE, JD
    SHIELDS, BJ
    BOUDOULAS, H
    LIMA, JJ
    CLINICAL CHEMISTRY, 1984, 30 (05) : 768 - 773
  • [39] THE DISCORDANT INFLUENCES OF INFARCT HEALING ON THE ELECTROPHYSIOLOGIC EFFECTS OF PROCAINAMIDE AND N-ACETYLPROCAINAMIDE
    NELSON, SD
    COYNE, KS
    MEIMER, J
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1995, 273 (01): : 315 - 319
  • [40] INHIBITION OF N-ACETYLATION OF PROCAINAMIDE AND RENAL CLEARANCE OF N-ACETYLPROCAINAMIDE BY PARA-AMINOBENZOIC ACID IN HUMANS
    TISDALE, JE
    RUDIS, MI
    PADHI, ID
    SVENSSON, CK
    WEBB, CR
    BORZAK, S
    WARE, JA
    KREPOSTMAN, A
    ZAROWITZ, BJ
    JOURNAL OF CLINICAL PHARMACOLOGY, 1995, 35 (09): : 902 - 910
12345